LTZ Therapeutics

LTZ Therapeutics is a biotech company focused on immunotherapy, developing novel therapies to improve outcomes for cancer and autoimmune disease patients. Their Myeloid Engager Platform enhances the body's immune response to fight disease, leveraging reverse translational science and a deep understanding of tumor microenvironment biology. The company's lead asset, LTZ-301, is advancing towards Phase 1 clinical trials.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $20M

Date: 30-Jul-2024

Investors: Lapam Capital, GL Ventures, K2 Venture Partners, Shunwei Capital

Markets: Biotechnology, Immunotherapy, Oncology, Autoimmune Diseases, Health Care, Medical, Drug Discovery

HQ: Redwood City, California, United States

Founded: 2022

Website: https://www.ltztherapeutics.com/

LinkedIn: https://www.linkedin.com/company/ltz-therapeutics

Twitter:

Instagram: